Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lauro Roberto

Pediatric Pulmonology Fresno, CA Medical Doctor

NPI 1194878512 CMS profile 280647

7471 N Fresno St, Fresno, CA 93720

Open in the dashboard

General payments

$10,494

534 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lauro Roberto of Fresno, CA is reported in the CMS Open Payments database as having received $10,494 across 534 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,352 63
2024 General $1,165 60
2023 General $2,017 94
2022 General $1,748 89
2021 General $1,043 62
2020 General $596 24
2019 General $2,573 142

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lauro Roberto
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Lauro Roberto were reported at $1,352. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Lauro Roberto Pediatric Pulmonology median Middle half National median
2019 $2,573 $151 $59–$495 $163
2020 $596 $107 $34–$339 $114
2021 $1,043 $125 $40–$511 $132
2022 $1,748 $133 $49–$428 $149
2023 $2,017 $138 $44–$494 $160
2024 $1,165 $132 $46–$398 $164
2025 $1,352 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Regeneron Healthcare Solutions, Inc. $1,477 55 payments
  2. AbbVie, Inc. $1,376 93 payments
  3. AstraZeneca Pharmaceuticals LP $985 52 payments
  4. Chiesi USA, Inc. $771 56 payments
  5. Baxter Healthcare $613 28 payments
  6. Novartis Pharmaceuticals Corporation $578 9 payments
  7. Vertex Pharmaceuticals Incorporated $549 22 payments
  8. Digestive Care, Inc. $536 8 payments
  9. Electromed, Inc. $499 35 payments
  10. Advanced Respiratory, Inc $461 29 payments
  11. Other $2,648 147 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,071 511 payments
  2. Education $347 22 payments
  3. Gift $76 1 payment
Products named General payments · program years 2019–2025
  1. CREON $1,338 91 payments
  2. DUPIXENT $1,231 49 payments
  3. Pertzye Gastroenterology $536 8 payments
  4. Pertzye Gastroenterology $536 8 payments
  5. Pertzye Gastroenterology $536 8 payments
  6. Pertzye Gastroenterology $536 8 payments
  7. BRONCHITOL $535 34 payments
  8. PERTZYE Cystic Fibrosis $475 29 payments
  9. Hillrom - Vest System Model 105 Home Care $462 21 payments
  10. TEZSPIRE $339 21 payments
  11. Other $5,204 296 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

534 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record